Clincosm LogoSign in Get a demo

Intrahepatic Cholangiocarcinoma

Showing NaN - NaN of 11
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Carcinoma, Intrahepatic Cholangiocarcinoma, Digestive System Tumors Trial in Guangzhou (Pemigatinib, PD-1 Inhibitors)

Recruiting
  • Carcinoma
  • +4 more
  • Guangzhou, Guangdong, China
    Lei Zhang
Jun 21, 2023

Intrahepatic Cholangiocarcinoma Trial in China, United States (Extend LymphAdenectomy)

Recruiting
  • Intrahepatic Cholangiocarcinoma
  • Extend LymphAdenectomy
  • Baltimore, Maryland
  • +12 more
Nov 7, 2022

/or PD-1 Inhibitors for Unresectable Intrahepatic

Completed
  • Intrahepatic Cholangiocarcinoma
  • hepatic arterial infusion chemotherapy (HAIC) of oxaliplatin, fluorouracil, and leucovorin (FOLFOX)
  • GuangZhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Aug 7, 2022

Intrahepatic Cholangiocarcinoma Trial in GuangZhou (HAIC Combined with Tislelizumab and Apatinib)

Recruiting
  • Intrahepatic Cholangiocarcinoma
  • HAIC Combined with Tislelizumab and Apatinib
  • GuangZhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Aug 4, 2022

Intrahepatic Cholangiocarcinoma Trial in Guangzhou (HAIC Combined with Tislelizumab and Apatinib)

Recruiting
  • Intrahepatic Cholangiocarcinoma
  • HAIC Combined with Tislelizumab and Apatinib
  • Guangzhou, Guangdong, China
    Sun Yat-Sen University Cancer Center
May 28, 2022

Intrahepatic Cholangiocarcinoma Trial in Guangzhou (Camrelizumab, Apatinib)

Recruiting
  • Intrahepatic Cholangiocarcinoma
  • Guangzhou, Guangdong, China
    Li Xu
Dec 8, 2021

Intrahepatic Cholangiocarcinoma Trial in Guangzhou (oxaliplatin , fluorouracil, and leucovorin, gemcitabine and cisplatin)

Recruiting
  • Intrahepatic Cholangiocarcinoma
  • oxaliplatin , fluorouracil, and leucovorin
  • gemcitabine and cisplatin
  • Guangzhou, Guangdong, China
    Cancer Center Sun Yat-sen University
Jul 7, 2021

Intrahepatic Cholangiocarcinoma Trial in Guangzhou (Lenvatinib)

Withdrawn
  • Intrahepatic Cholangiocarcinoma
  • Guangzhou, Guangdong, China
    Cancer Center Sun Yat-sen University
May 19, 2020

Intrahepatic Cholangiocarcinoma Trial in Guangzhou (irinotecan, oxaliplatin , fluorouracil, and leucovorin, gemcitabine and

Unknown status
  • Intrahepatic Cholangiocarcinoma
  • irinotecan, oxaliplatin , fluorouracil, and leucovorin
  • gemcitabine and oxaliplatin
  • Guangzhou, Guangdong, China
  • +1 more
Dec 3, 2019

Intrahepatic Cholangiocarcinoma Trial in Guangzhou (Lenvatinib, PD-1 antibody)

Suspended
  • Intrahepatic Cholangiocarcinoma
  • Guangzhou, Guangdong, China
    Cancer Center Sun Yat-sen University
Jan 25, 2019

VEGF Signaling Promotes Cell Growth and Metastasis in

Unknown status
  • Intrahepatic Cholangiocarcinoma
  • surgical treatment
  • Guangzhou, Guangdong, China
    First Affiliated Hospital, Sun Yat-Sen University
Aug 5, 2013